Literature DB >> 6231575

[Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol].

F Deméocq, P Carton, C Patte, O Oberlin, D Sarrazin, J Lemerle.   

Abstract

From April, 1978 to December, 1982, 87 cases of Ewing's sarcoma were registered in 12 centres of paediatric oncology in France. The results of a therapeutic protocol consisting of intensive chemotherapy (vincristine, cyclophosphamide and actinomycin with or without adriamycin) prior to tumoral irradiation, followed by maintenance chemotherapy are reported after 3 years' follow-up from the beginning of treatment. In localized sarcomas, complete remission (66/70) persisted without relapse or metastasis in 54% of the cases (78% in sarcomas of long bones, and 37% in sarcomas of short bones). In non-metastatic sarcomas of the ribs, the first remission persisted in 7/14 patients (50%). All these patients had been initially treated with chemotherapy, radiotherapy and surgical excision. These preliminary results emphasize the value of co-operative therapeutic trials in a rare tumour, demonstrate the effectiveness of the initial chemotherapy used against Ewing's sarcoma and are in favour of a combined treatment, including systematic excision, for Ewing's sarcomas affecting the ribs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231575

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents.

Authors:  V Göbel; H Jürgens; G Etspüler; H Kemperdick; R M Jungblut; U Stienen; U Göbel
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP).

Authors:  F Deméocq; O Oberlin; E Benz-Lemoine; A Boilletot; J C Gentet; J M Zucker; C Behar; P Poutard; D Olive; M Brunat-Mentigny
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Histopathological predictive factors in Ewing's sarcoma of bone and clinicopathological correlations. A retrospective study of 261 cases.

Authors:  A Llombart-Bosch; G Contesso; M Henry-Amar; M J Lacombe; O Oberlin; J Dubousset; J Rouëssé; D Sarrazin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Establishing long-term survival and cure in young patients with Ewing's sarcoma.

Authors:  C L Weston; C Douglas; A W Craft; I J Lewis; D Machin
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.